Lv11
20 积分 2025-08-18 加入
Cytosine base editing enables quadruple-edited allogeneic CART cells for T-ALL
9小时前
待确认
Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia
9小时前
已完结
Engineered mRNAs With Stable Structures Minimize Double-stranded RNA Formation and Increase Protein Expression
28天前
已完结
BEAM-201 for the Treatment of Relapsed and/or Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL): Initial Data from the Phase (Ph) 1/2 Dose-Exploration, Dose-Expansion, Safety, and Efficacy Study of Multiplex Base-Edited Allogeneic Anti-CD7 CAR-T-Cells
1个月前
已完结
The use of intracellular single-chain antibody fragments to inhibit specifically the expression of cell surface molecules
2个月前
已完结
Eradication of T-ALL Cells by CD7-targeted Universal CAR-T Cells and Initial Test of Ruxolitinib-based CRS Management
2个月前
已完结
Donor-derived CD7 CAR T cells for pediatric and adult relapsed/refractory T-ALL/LBL: a phase 2 trial
2个月前
已完结
Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia
2个月前
已完结
CD7 targeted “off-the-shelf” CAR-T demonstrates robust in vivo expansion and high efficacy in the treatment of patients with relapsed and refractory T cell malignancies
2个月前
已完结
Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma
2个月前
已完结
皖公网安备34019202002308
